BD makes Vincent Forlenza CEO
This article was originally published in Clinica
Becton Dickinson has appointed company stalwart and current president Vincent Forlenza to the additional role of CEO, effective 1 October. He replaces Edward Ludwig, who has been BD's CEO since 2000, and will serve as executive chairman of the board until June 2012. The appointment is the culmination of BD's long-term succession planning, which it started in 2008 when Mr Forlenza was promoted to president, where he was responsible for the medical, diagnostics and biosciences divisions, international and quality operations (www.clinica.co.uk, 11 November 2008). Mr Forlenza, who has been at BD since 1980, also became chief operating officer in July 2010. Meanwhile, BD has declared a quarterly dividend of $0.41 per share, payable on 30 September, to shareholders on the register on 9 September. The company is due to report its third-quarter financial results on 2 August.